ClinConnect ClinConnect Logo
Search / Trial NCT03468998

The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Mar 12, 2018

Trial Information

Current as of July 05, 2025

Completed

Keywords

Bone Allograft Particle Size Ridge Preservation Ridge Augmentation Socket Grafting Histology New Bone

ClinConnect Summary

This study is a prospective, two-arm, randomized trial that will evaluate and compare the bone healing following ridge preservation of extraction sockets (RP, Arms 1 and 2) or lateral ridge augmentation of edentulous sites (RA, Arms 3 and 4) using either small particle (SP) or large particle (LP) mineralized cortico-cancellous bone allografts in a total of 48 patients (12 in each arm).

Study approval was obtained from the university's institutional review board. Qualifying participants and defects are randomized following a computerized permutation block to receive either LP or SP allograf...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • English speaking
  • At least 18 years old
  • Must be a patient of the UAB Dental School
  • Able to read and understand informed consent document
  • Need for implants to replace missing tooth or teeth in at least one quadrant of the mouth.
  • Hopeless tooth or teeth planned to be replaced with dental implant(s)_socket with residual 4 walls following minimally invasive tooth extraction (a dehiscence of \<3mm may be included) or insufficient alveolar ridge width for endosseous implant placement defined as 5mm or less as determined by bone sounding and cone beam computed tomography (CBCT) scan.
  • Patient and/or guardian is willing and able to comply with the preoperative and postoperative diagnostic and clinical evaluations required.
  • Exclusion Criteria:
  • Non-English speaking
  • Less than 18 years old
  • Smokers/tobacco users (\>10 cigarettes/day)
  • Patients with systemic pathologies or conditions contraindicating oral surgical procedures or adversely affecting wound healing
  • Patients with significant medical conditions or habits expected to interfere with bony healing.
  • Patient is a poor compliance risk (i.e., poor oral hygiene, history of alcohol or drug abuse)
  • Bone dehiscence of \>4mm following tooth extraction or Vertical loss of bone at edentulous ridge

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Birmingham, Alabama, United States

Patients applied

0 patients applied

Trial Officials

Ramzi V Abou-Arraj, DDS, MS

Principal Investigator

University of Alabama at Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials